Your browser doesn't support javascript.
loading
Risankizumab for severe psoriasis: a case of successful retreatment without induction after 15 months of discontinuation.
Mortato, Edoardo; Baratta, Silvia; Viola, Riccardo; DE Caro, Anna P; Loconsole, Francesco.
Afiliação
  • Mortato E; Section of Dermatology and Venereology, Department of Biomedical Sciences and Human Oncology, University of Bari, Bari, Italy.
  • Baratta S; Section of Dermatology and Venereology, Department of Biomedical Sciences and Human Oncology, University of Bari, Bari, Italy.
  • Viola R; Section of Dermatology and Venereology, Department of Biomedical Sciences and Human Oncology, University of Bari, Bari, Italy.
  • DE Caro AP; Section of Dermatology and Venereology, Department of Biomedical Sciences and Human Oncology, University of Bari, Bari, Italy.
  • Loconsole F; Section of Dermatology and Venereology, Department of Biomedical Sciences and Human Oncology, University of Bari, Bari, Italy - franciscus59@gmail.com.
Ital J Dermatol Venerol ; 159(2): 199-200, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38650500
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Anticorpos Monoclonais Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Anticorpos Monoclonais Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article